$MNKD Recent Headlines 3 overlooked stocks loved by

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2014 at 6:48 PM

$MNKD Recent Headlines

3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:54 p.m. April 1, 2014 - Wallace Witkowski
7 gut checks before the stock market's opening bell 6:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 11:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 1:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 8:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 10:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi

MannKind continues its bull run 12:16 p.m. Today - Seeking Alpha
MannKind (MNKD) Surges to 52-Week High as Afrezza Approval Approaches 11:58 a.m. Today - TheStreet.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. Today - InvestorPlace.com
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short 8:59 a.m. June 3, 2014 - Seeking Alpha
MannKind (MNKD) at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
MannKind's (MNKD) Management Presents at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT LPCN MNKD UEC 10:00 a.m. June 2, 2014 - InvestorPlace.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD LCI RDY NBIX 7:45 a.m. May 30, 2014 - InvestorPlace.com
The Seven Deadly Sins of Biotech Investing 7:00 a.m. May 29, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Short MannKind On Afrezza Approval? 3:33 p.m. May 27, 2014 - Seeking Alpha
MannKind Annual Shareholder Meeting Provides Further Optimism For Afrezza And Technosphere Platform 3:05 p.m. May 27, 2014 - Seeking Alpha
One Small Step For Afrezza, One Huge Step For MannKind? 10:44 a.m. May 27, 2014 - benzinga.com
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
Hottest Healthcare Stocks Now – CLVS CYH AZN MNKD 9:00 a.m. May 20, 2014 - InvestorPlace.com
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision 10:03 a.m. May 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Twelve Analyst Stocks to Buy Under $10 for Big Upside 8:35 a.m. May 17, 2014 - 247WallSt.com

MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
Insider Trading Alert - Free Research of General Motors, Apple, RF Micro Devices, MannKind, Sirius XM, and Plug Power 8:55 a.m. April 3, 2014 - PR Newswire - PRF
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes 5:47 p.m. April 1, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPOC Energy's Hiring Push Signals Growth Surge

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Euroandinos Paita Closes Consent for 2037 Notes

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Terra Kaffe's Big Win with Oprah's Endorsement

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Pine AI Unveils AI Studio & Real-World Call Feature

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Missoula Inventor Offers Handy Phone Solution on the Move

Adjustable Convenience for the Modern Commuter When you're commuting or just lounging around, less hand strain and more comfort sounds like a no-brainer, right? Well, an inventive soul from Missoula, Montana, just might have cracked this little nut with a gizmo they're calling the COMMUTER PHONE. Imagine never having to juggle your phone during those bumpy moments on the...

Eve Air Mobility's Vector System Proves Its Worth

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

55 Broad Street's New Face: A $500M Revamp with RXR

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Health Net Invests $3 Million in Stockton Housing

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...